Literature DB >> 32585035

The role of complement in arterial hypertension and hypertensive end organ damage.

Ulrich O Wenzel1, Claudia Kemper2,3, Marlies Bode1.   

Abstract

Increasing evidence indicates that hypertension and hypertensive end organ damage are not only mediated by haemodynamic injury but that inflammation also plays an important role. The complement system protects the host from a hostile microbial environment and maintains tissue and cell integrity through the elimination of altered or dead cells. As an important effector arm of innate immunity, it plays also central roles in the regulation of adaptive immunity. Thus, complement activation may drive the pathology of hypertension through its effects on innate and adaptive immune responses, aside from direct effects on the vasculature. Recent experimental data strongly support a role for complement in all stages of arterial hypertension. The remarkably similar clinical and histopathological features of malignant nephrosclerosis and atypical haemolytic uraemic syndrome suggest also a role for complement in the development of malignant nephrosclerosis. Here, we review the role of complement in hypertension and hypertensive end organ damage. LINKED ARTICLES: This article is part of a themed issue on Canonical and non-canonical functions of the complement system in health and disease. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.14/issuetoc.
© 2020 The British Pharmacological Society.

Entities:  

Keywords:  C1q; C3; C3aR; C5aR1; C5aR2; arterial hypertension; atypical hemolytic uremic syndrome; malignantnephrosclerosis

Mesh:

Substances:

Year:  2020        PMID: 32585035     DOI: 10.1111/bph.15171

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  Effect of eplerenone on cognitive impairment in spontaneously hypertensive rats.

Authors:  Zhongqiao Lin; Yan Lu; Sheng Li; Yiying Li; Han Li; Lin Li; Lei Wang
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

Review 2.  Autoimmune-mediated renal disease and hypertension.

Authors:  Erika I Boesen; Rahul M Kakalij
Journal:  Clin Sci (Lond)       Date:  2021-09-17       Impact factor: 6.876

3.  Association of Complement-Related Proteins in Subjects With and Without Second Trimester Gestational Diabetes.

Authors:  Manjunath Ramanjaneya; Alexandra E Butler; Meis Alkasem; Mohammed Bashir; Jayakumar Jerobin; Angela Godwin; Abu Saleh Md Moin; Lina Ahmed; Mohamed A Elrayess; Steven C Hunt; Stephen L Atkin; Abdul-Badi Abou-Samra
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-30       Impact factor: 5.555

4.  Effects of irbesartan on phenotypic alterations in monocytes and the inflammatory status of hypertensive patients with left ventricular hypertrophy.

Authors:  Jingsi Zhang; Lina Yang; Yanchun Ding
Journal:  BMC Cardiovasc Disord       Date:  2021-04-20       Impact factor: 2.298

Review 5.  The state of complement in COVID-19.

Authors:  Behdad Afzali; Marina Noris; Bart N Lambrecht; Claudia Kemper
Journal:  Nat Rev Immunol       Date:  2021-12-15       Impact factor: 108.555

Review 6.  Mosaic theory revised: inflammation and salt play central roles in arterial hypertension.

Authors:  Felicitas E Hengel; Jean-Pierre Benitah; Ulrich O Wenzel
Journal:  Cell Mol Immunol       Date:  2022-03-30       Impact factor: 22.096

7.  Potential Involvement of Complement Activation in Kidney Vascular Lesions of Arterionephrosclerosis.

Authors:  Xuejing Chen; Yu Wang; Xiaojuan Yu; Suxia Wang; Minghui Zhao
Journal:  Front Med (Lausanne)       Date:  2022-03-31

8.  A Flow Cytometry-Based Assay for the Measurement of Total Complement Activity in the Serum and Clinical Practice.

Authors:  Xuewei Ding; Shijun Li; Hui Liu
Journal:  Dis Markers       Date:  2022-01-10       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.